Stereotactic body radiation therapy for low and intermediate risk prostate cancer—Results from a multi-institutional clinical trial

Overview of attention for article published in European Journal of Cancer (1965), March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 13 news outlets
blogs: 2 blogs
policy: 1 policy source
twitter: 32 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user
reddit: 2 Redditors
guideline: 1 clinical guideline source

Readers on

mendeley: 116 Mendeley

So far, Altmetric has seen 34 X posts from 32 X users, with an upper bound of 134,181 followers.

@ProtonStorey @DrSpratticus @urogeek Dose escalation in SBRT (50Gy+) is a problem without spacers (very serious toxicity - see Hannan et al https://t.co/cHcMQqNTyz). Higher doses will be needed for higher risk disease. Also move towards 2 shot etc. Henc…

@palmend @medicalphysics Tiene pinta de que sí. https://t.co/XQEY5cYKMG

RT @Monthy_A: SBRT en cáncer dee próstata consigue tasas de control tumoral del 99% a 5 años #avances #RTpróstata https://t.co/J6tWREaubr

Full paper if you (chasers) want to dig in and do your "dd".Same population as $sphs trial but different results eh? https://t.co/NHYT24rJov

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.